These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 10160079)

  • 1. Formulary management of macrolide antibiotics.
    Guay DR
    Pharmacoeconomics; 1995 Dec; 8(6):491-512. PubMed ID: 10160079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulary considerations in selection of beta-blockers.
    Yedinak KC
    Pharmacoeconomics; 1993 Aug; 4(2):104-21. PubMed ID: 10150154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating fluoroquinolones into the hospital formulary.
    Bertino JS
    Pharmacotherapy; 2001 Oct; 21(10 Pt 2):273S-283S. PubMed ID: 11642692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide antibiotics in paediatric infectious diseases.
    Guay DR
    Drugs; 1996 Apr; 51(4):515-36. PubMed ID: 8706592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulary management: antibiotics and therapeutic interchange.
    Massoomi F
    Pharm Pract Manag Q; 1996 Oct; 16(3):11-8. PubMed ID: 10166231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies in antimicrobial therapy: formulary decisions on third-generation cephalosporins.
    Barriere SL
    Am J Hosp Pharm; 1986 Mar; 43(3):625-9. PubMed ID: 3706317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous azithromycin.
    Garey KW; Amsden GW
    Ann Pharmacother; 1999 Feb; 33(2):218-28. PubMed ID: 10084418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the formulary status of quinolone antibiotics: one institution's approach.
    Nightingale CH; Lubowski T; On A; Quintiliani R
    Hosp Formul; 1992 May; 27(5):509-10, 513-4, 516. PubMed ID: 10128710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A guide to selection and appropriate use of macrolides in skin infections.
    Parsad D; Pandhi R; Dogra S
    Am J Clin Dermatol; 2003; 4(6):389-97. PubMed ID: 12762831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients.
    Langtry HD; Brogden RN
    Drugs; 1997 Jun; 53(6):973-1004. PubMed ID: 9179528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost and quality considerations in antibiotic formulary management.
    Ritchie DF
    Pharm Pract Manag Q; 1996 Jul; 16(2):4-8. PubMed ID: 10161610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin.
    Drusano G
    Clin Microbiol Infect; 2001; 7 Suppl 3():24-9. PubMed ID: 11523559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.
    Zhanel GG; Hartel E; Adam H; Zelenitsky S; Zhanel MA; Golden A; Schweizer F; Gorityala B; Lagacé-Wiens PR; Walkty AJ; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2016 Dec; 76(18):1737-1757. PubMed ID: 27909995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy.
    Kirst HA; Sides GD
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1419-22. PubMed ID: 2684005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential costs and outcomes among pediatric oral antibiotic formulations identified from a large prescription database.
    Bowman L; Faulkner D; Lucy L
    J Chemother; 2000 Feb; 12(1):72-8. PubMed ID: 10768518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effective treatment of lower respiratory tract infections.
    Garrelts JC; Herrington AM
    Pharmacoeconomics; 1996 Jul; 10(1):36-58. PubMed ID: 10160469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effective approaches to the treatment of community-acquired pneumonia in the era of resistance.
    Kuti JL; Capitano B; Nicolau DP
    Pharmacoeconomics; 2002; 20(8):513-28. PubMed ID: 12109917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolide antibiotics.
    Farrington E
    Pediatr Nurs; 1998; 24(5):433-4, 437-46. PubMed ID: 9832903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin.
    Bahal N; Nahata MC
    Ann Pharmacother; 1992 Jan; 26(1):46-55. PubMed ID: 1318761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ketolides: a critical review.
    Zhanel GG; Walters M; Noreddin A; Vercaigne LM; Wierzbowski A; Embil JM; Gin AS; Douthwaite S; Hoban DJ
    Drugs; 2002; 62(12):1771-804. PubMed ID: 12149046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.